$15.73 -0.05 (%) Sarepta Therapeutics Inc - NASDAQ

Nov. 21, 2014 | 04:00 PM

Partner Headlines

  1. Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close At Records High

    Benzinga | Oct. 31, 2014 | 16:54PM EST
  2. Morning Market Movers

    Benzinga | Oct. 31, 2014 | 09:55AM EST
  3. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 31, 2014 | 08:15AM EST
  4. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  5. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  6. Baird Downgrades Sarepta Therapeutics To Neutral

    Benzinga | Oct. 28, 2014 | 07:54AM EST
  7. Fast Money Traders Discuss Merck, Garmin And Sarepta Therapeutics

    Benzinga | Oct. 27, 2014 | 20:18PM EST
  8. Sarepta tumbles on drug delay

    IBD | Oct. 27, 2014 | 18:55PM EST
  9. Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook

    Benzinga | Oct. 27, 2014 | 16:58PM EST
  10. Mid-Afternoon Market Update: NQ Mobile Climbs On SEC Filing; Huntsman Shares Slide

    Benzinga | Oct. 27, 2014 | 15:15PM EST
  11. Sarepta Gets Delayed And The Stock Gets Drilled

    Benzinga | Oct. 27, 2014 | 14:51PM EST
  12. Mid-Day Market Update: Micron Gains On Buyback Announcement; Sarepta Shares Dip

    Benzinga | Oct. 27, 2014 | 12:41PM EST
  13. Mid-Morning Market Update: Markets Down; Merck Posts Upbeat Earnings

    Benzinga | Oct. 27, 2014 | 11:12AM EST
  14. Morning Market Losers

    Benzinga | Oct. 27, 2014 | 10:07AM EST
  15. Benzinga's Top #PreMarket Losers

    Benzinga | Oct. 27, 2014 | 08:21AM EST
  16. Sarepta Offers Regulatory Update Related to Eteplirsen

    Benzinga | Oct. 27, 2014 | 07:08AM EST
  17. Making Money With Charles Payne: 10/24/14

    FoxBusiness | Oct. 24, 2014 | 18:00PM EST
  18. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness | Oct. 17, 2014 | 14:52PM EST
  19. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga | Oct. 17, 2014 | 10:58AM EST
  20. Morning Market Movers

    Benzinga | Oct. 17, 2014 | 09:49AM EST
  21. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 17, 2014 | 08:07AM EST
  22. Making Money With Charles Payne: 10/16/14

    FoxBusiness | Oct. 16, 2014 | 18:00PM EST
  23. Sarepta Shares Now Up Over 5% After-Hours

    Benzinga | Oct. 16, 2014 | 16:27PM EST
  24. Making Money With Charles Payne: 10/08/14

    FoxBusiness | Oct. 8, 2014 | 18:00PM EST
  25. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga | Oct. 8, 2014 | 13:04PM EST
  26. Making Money With Charles Payne: 10/07/14

    FoxBusiness | Oct. 7, 2014 | 18:00PM EST
  27. Making Money With Charles Payne: 10/0614

    FoxBusiness | Oct. 6, 2014 | 18:00PM EST
  28. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga | Oct. 6, 2014 | 14:08PM EST
  29. Making Money With Charles Payne: 10/01/14

    FoxBusiness | Oct. 1, 2014 | 18:00PM EST
  30. Benzinga's Volume Movers

    Benzinga | Oct. 1, 2014 | 10:18AM EST
  31. Morning Market Movers

    Benzinga | Oct. 1, 2014 | 09:39AM EST
  32. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 1, 2014 | 08:06AM EST
  33. Making Money With Charles Payne: 09/30/14

    FoxBusiness | Oct. 1, 2014 | 06:18AM EST
  34. Sarepta Reports Favorable Safety Results from Phase I Study of AVI-7100

    Benzinga | Sep. 30, 2014 | 07:32AM EST
  35. Credit Suisse Bullish On Sarepta Therapeutics Inc

    Benzinga | Sep. 24, 2014 | 09:22AM EST
  36. Biotechs That Might Benefit From Ebola

    Benzinga | Aug. 11, 2014 | 15:29PM EST
  37. Tekmira Ebola Drug Hold Lifted By FDA, Stock Soars

    IBD | Aug. 8, 2014 | 14:04PM EST
  38. Benzinga's Top #PreMarket Gainers

    Benzinga | Aug. 5, 2014 | 08:19AM EST
  39. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga | Jul. 30, 2014 | 16:43PM EST
  40. Sarepta Up 12% As FDA Is 'Actively Engaged' On Drug Application

    Benzinga | Jul. 30, 2014 | 11:33AM EST
  41. Morning Market Losers

    Benzinga | Jul. 24, 2014 | 09:54AM EST
  42. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 24, 2014 | 08:16AM EST
  43. Shares of Sarepta Therapeutics Plummet on CSO Termination

    Benzinga | Jul. 24, 2014 | 07:42AM EST
  44. Mid-Afternoon Market Movers For July 10, 2014

    Benzinga | Jul. 10, 2014 | 15:42PM EST
  45. Deutsche Bank Questions Long-Term Efficacy Of Sarepta's Eteplirsen Following Trial News

    Benzinga | Jul. 10, 2014 | 15:24PM EST
  46. Lumber Liquidators Falls On Weak Forecast; Zumiez Shares Spike Higher

    Benzinga | Jul. 10, 2014 | 12:44PM EST
  47. Markets Open Lower; Family Dollar Profit Misses Estimates

    Benzinga | Jul. 10, 2014 | 10:40AM EST
  48. Morning Market Losers

    Benzinga | Jul. 10, 2014 | 09:51AM EST
  49. UPDATE: Sarepta Therapeutics Announces $100M Proposed Public Offering of Common Stock

    Benzinga | Apr. 22, 2014 | 16:44PM EST
  50. Five Star Stock Watch: Sarepta Therapeutics

    Benzinga | Apr. 22, 2014 | 12:54PM EST
Trading Center